Q4 2021 Holdings
Filed 2022-02-14 | 376 holdings | $24.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $165 | 7,151 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $165 | 12,482 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $165 | 7,086 | 0.0% |
| NGM Biopharmaceuticals Inc(NGMUSD) | COM | 62921N105 | $165 | 9,301 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $165 | 10,456 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $165 | 60,836 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $166 | 1,785 | 0.0% |
| Bioxcel Therapeutics Inc(BTAIEUR) | COM | 09075P105 | $166 | 8,164 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $167 | 13,699 | 0.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $167 | 14,798 | 0.0% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $167 | 19,648 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $167 | 2,203 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $167 | 5,112 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $167 | 22,227 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $168 | 1,425 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $168 | 11,305 | 0.0% |
| Affimed N V | COM | N01045108 | $169 | 30,588 | 0.0% |
| Forma Therapeutics Hldgs Inc | SHS | 34633R104 | $169 | 11,902 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $169 | 10,324 | 0.0% |
| Vaxart Inc(VXRT) | COM NEW | 92243A200 | $169 | 26,883 | 0.0% |
| Aligos Therapeutics Inc | COM | 01626L105 | $169 | 14,209 | 0.0% |
| Dice Therapeutics Inc | COM | 23345J104 | $169 | 6,683 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $170 | 52,815 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $170 | 18,150 | 0.0% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $170 | 20,379 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $170 | 52,145 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $170 | 5,787 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $170 | 6,746 | 0.0% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $171 | 2,013 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $171 | 12,548 | 0.0% |
| CUE Biopharma Inc(CUE) | COM | 22978P106 | $171 | 15,125 | 0.0% |
| Amyris Inc(AMRSEUR) | COM NEW | 03236M200 | $171 | 31,527 | 0.0% |
| Applied Molecular Trans Inc | COM | 03824M109 | $172 | 12,313 | 0.0% |
| Kinnate Biopharma Inc | COM | 49705R105 | $172 | 9,725 | 0.0% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $172 | 13,815 | 0.0% |
| VBI Vaccines Inc CDA(VAC2USD) | COM NEW | 91822J103 | $172 | 73,329 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $172 | 12,230 | 0.0% |
| Compugen LTD(CGEN) | ORD | M25722105 | $173 | 40,161 | 0.0% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $173 | 17,290 | 0.0% |
| Precigen Inc(PGEN) | COM | 74017N105 | $173 | 46,531 | 0.0% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $173 | 12,277 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $174 | 6,010 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $174 | 1,183 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $175 | 9,182 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $175 | 3,693 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $175 | 8,266 | 0.0% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $176 | 36,911 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $176 | 11,289 | 0.0% |
| Immunitybio Inc(IBRX) | COM | 45256X103 | $176 | 28,969 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $176 | 8,355 | 0.0% |